Genetic association between interleukin-10 gene promoter region polymorphisms and type 1 diabetes age-at-onset

被引:48
作者
Ide, A
Kawasaki, E
Abiru, N
Sun, FY
Takahashi, R
Kuwahara, H
Fujita, N
Kita, A
Oshima, K
Sakamaki, H
Uotani, S
Yamasaki, H
Yamaguchi, Y
Eguchi, K
机构
[1] Nagasaki Univ, Sch Med, Unit Metab Diabet & Clin Nutr, Nagasaki 8528501, Japan
[2] Nagasaki Univ, Sch Med, Dept Internal Med, Nagasaki 8528501, Japan
关键词
type; 1; diabetes; IL-10; onset age; gene polymorphism; Japanese;
D O I
10.1016/S0198-8859(02)00417-2
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
This study investigated whether interleukin-10 (IL-10) gene promoter region polymorph isms are associated with Susceptibility to or clinical presentation of type 1 diabetes. The frequency of -1082G/A, -819C/T, and -592C/A polymorphisms was analyzed in 128 Japanese patients with type 1 diabetes and in 107 healthy control subjects in a case-controlled study. The allelic and haplotypic frequencies of the IL-10 gene promoter region polymorphisms were similar in patients with type 1 diabetes and in control subjects. However, the -819T and -592A allele were associated with adult-onset (>18 years) of the disease (p = 0.037). Furthermore, the frequency of ATA haplotype was increased in adult-onset patients than that in early-onser patients (less than or equal to18 years; p = 0.037). Among the genotypes comprising ATA haplotype, the frequency of ATA/ATA was significantly higher in adult-onset patients than in early-onset patients (p = 0.004). These results Suggest that the IL-10 gene promoter polymorphisms are associated with the age-at-onset in Japanese patients with type 1 diabetes. (C) American Society for Histocompatibility and Immunogenetics, 2002. Published by Elsevier Science Inc.
引用
收藏
页码:690 / 695
页数:6
相关论文
共 31 条
[1]   T helper type 1 and 2 cytokines mediate the onset and progression of type I (insulin-dependent) diabetes [J].
Almawi, WY ;
Tamim, H ;
Azar, ST .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (05) :1497-1502
[2]  
ATKINSON MA, 1994, NEW ENGL J MED, V331, P1428
[3]   The paradoxical effects of interleukin 10 in the immunoregulation of autoimmune diabetes [J].
Balasa, B ;
Sarvetnick, N .
JOURNAL OF AUTOIMMUNITY, 1996, 9 (02) :283-286
[4]   SUSCEPTIBILITY TO HUMAN TYPE-1 DIABETES AT IDDM2 IS DETERMINED BY TANDEM REPEAT VARIATION AT THE INSULIN GENE MINISATELLITE LOCUS [J].
BENNETT, ST ;
LUCASSEN, AM ;
GOUGH, SCL ;
POWELL, EE ;
UNDLIEN, DE ;
PRITCHARD, LE ;
MERRIMAN, ME ;
KAWAGUCHI, Y ;
DRONSFIELD, MJ ;
POCIOT, F ;
NERUP, J ;
BOUZEKRI, N ;
CAMBONTHOMSEN, A ;
RONNINGEN, KS ;
BARNETT, AH ;
BAIN, SC ;
TODD, JA .
NATURE GENETICS, 1995, 9 (03) :284-292
[5]  
Buzzetti R, 1998, DIABETES METAB REV, V14, P111, DOI 10.1002/(SICI)1099-0895(199806)14:2<111::AID-DMR211>3.3.CO
[6]  
2-U
[7]   AGE-DEPENDENT HLA GENETIC-HETEROGENEITY OF TYPE-1 INSULIN-DEPENDENT DIABETES-MELLITUS [J].
CAILLATZUCMAN, S ;
GARCHON, HJ ;
TIMSIT, J ;
ASSAN, R ;
BOITARD, C ;
DJILALISAIAH, I ;
BOUGNERES, P ;
BACH, JF .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (06) :2242-2250
[8]  
CHEN WF, 1991, J IMMUNOL, V147, P528
[9]  
Crawley E, 1999, ARTHRITIS RHEUM-US, V42, P1101, DOI 10.1002/1529-0131(199906)42:6<1101::AID-ANR6>3.0.CO
[10]  
2-Y